Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023279 |
---|---|
Receipt number | R000017022 |
Scientific Title | The necessary of heparin bridging therapy for the patients taking warfarin or Indirect and Direct Factor Xa Inhibitors undergoing colonic endoscopic mucosal resection. |
Date of disclosure of the study information | 2016/07/21 |
Last modified on | 2018/03/14 21:18:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/07/21 19:53:56 | ||
2 | Update | 2016/10/07 22:31:23 | Public title Public title |
|
3 | Update | 2016/10/07 22:37:15 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes |
|
4 | Update | 2016/10/07 22:39:05 | Interventions/Control_1 Key inclusion criteria |
|
5 | Update | 2017/01/20 20:32:02 | Publication of results Results Results |
|
6 | Update | 2017/07/22 16:38:19 | Results Results |
|
7 | Update | 2017/11/10 20:31:04 | Results Results |
|
8 | Update | 2018/01/26 21:00:40 | Results Results |
|
9 | Update | 2018/03/14 20:47:24 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results Results Results |
|
10 | Update | 2018/03/14 21:18:11 | Results Results |